A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients

We determined the therapeutic efficacy of atractylenolide I (ATR), extracted from largehead atractylodes rhizome, in managing gastric cancer cachexia (GCC), and interpreted its probable pharmacological mechanism via investigating tumor necrosis factor alpha (TNF-α), interleukin-1 (IL-1), interleukin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Jia, Zhongwu, Dong, Lei, Wang, Rui, Qiu, Genquan
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Original Article - Clinical Analyses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529387/
https://www.ncbi.nlm.nih.gov/pubmed/18830451
http://dx.doi.org/10.1093/ecam/nem031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529387/
https://www.ncbi.nlm.nih.gov/pubmed/18830451
http://dx.doi.org/10.1093/ecam/nem031

Ejemplares similares